Data / Form D filings / Marker Therapeutics, Inc.
Marker Therapeutics, Inc.: Form D filings
Marker Therapeutics, Inc., a biotechnology company in Houston, TX, filed 10 Form D notices with the SEC between 2009 and 2024. The latest, on December 30, 2024, reports $16.1 million sold of a $16.1 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 HOLCOMBE BLVD, SUITE BCM-A, MS: BCM251, Houston, TX, 77021
- Phone
- (713) 400-6400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1094038
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | New notice | $16,100,000 | $16,100,000 | 5 | Dec 23, 2024 | sec.gov | |
| May 24, 2018 | New notice | $3,100,000 | $3,100,000 | 1 | May 18, 2018 | sec.gov | |
| Jun 29, 2017 | New notice | $6,190,002 | $6,190,002 | 87 | Jun 26, 2017 | sec.gov | |
| Sep 9, 2016 | Amendment | $5,000,000 | $3,135,195 | $1,864,805 | 46 | Aug 10, 2016 | sec.gov |
| Aug 25, 2016 | New notice | Indefinite | $0 | 11 | Aug 11, 2016 | sec.gov | |
| Aug 23, 2016 | New notice | $5,000,000 | $2,426,195 | $2,573,805 | 29 | Aug 10, 2016 | sec.gov |
| Jun 2, 2010 | New notice | $1,275,000 | $1,275,000 | 4 | May 24, 2010 | sec.gov | |
| Nov 10, 2009 | New notice | $700,000 | $700,000 | 3 | Sep 28, 2009 | sec.gov | |
| Nov 10, 2009 | New notice | $350,000 | $350,000 | 1 | Aug 31, 2009 | sec.gov | |
| Nov 10, 2009 | New notice | $135,000 | $135,000 | 10 | Feb 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Juan Vera | Executive Officer, Director | |
| Steven Elms | Director | |
| John Wilson | Director | |
| Katharine Knobil | Director | |
| David Eansor | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Marker Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.